FBXO32 and cancer: Mechanistic studies showed that inhibition of p-STAT3 within the mouse cancer cachexia model with C188-9 treatment reduced transcript levels of muscle-specific ubiquitin ligases MAFbx/Atrogin-1 and MuRF1 and improved protein synthesis in muscles of mice bearing tumors [147].